Transgene SA
0.7160
14-February-25 11:27:28
15 minutes delayed
Stocks
+0.0070
+0.99%
Today's range
0.7160 - 0.7200
ISIN
FR0005175080
Source
Cboe
-
Transgene’s Combined General Meeting of May 15, 2024
15 May 2024 11:45:00 By Nasdaq GlobeNewswire
-
Transgene provides business and financial update for Q1 2024
14 May 2024 11:45:00 By Nasdaq GlobeNewswire
-
Availability of Preparatory Documents for the Combined General Meeting of May 15, 2024
24 Apr 2024 11:45:00 By Nasdaq GlobeNewswire
-
Availability of Transgene's 2023 Universal Registration Document
11 Apr 2024 11:45:00 By Nasdaq GlobeNewswire
-
09 Apr 2024 11:45:00 By Nasdaq GlobeNewswire
-
27 Mar 2024 12:45:00 By Nasdaq GlobeNewswire
-
27 Mar 2024 12:45:00 By Nasdaq GlobeNewswire
-
Transgene Announces Upcoming Investor Meetings
18 Mar 2024 12:45:00 By Nasdaq GlobeNewswire
-
Transgene to Present New Data on TG4050, an Individualized Cancer Vaccine, at AACR 2024
06 Mar 2024 01:30:00 By Nasdaq GlobeNewswire
-
05 Mar 2024 01:30:00 By Nasdaq GlobeNewswire
-
22 Jan 2024 11:45:00 By Nasdaq GlobeNewswire
-
Transgene Announces Financial Calendar for 2024
22 Jan 2024 02:00:00 By Nasdaq GlobeNewswire
-
08 Jan 2024 11:45:00 By Nasdaq GlobeNewswire
-
Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of December 31, 2023
04 Jan 2024 11:45:00 By Nasdaq GlobeNewswire